Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.51 |
| ▸ | HPGD | P15428 | 4/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | PGR | P06401 | 2/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | PDE4A | P27815 | 1/20 | 0.51 |
| ▸ | HRH1 | P35367 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.51 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.44 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30234843 | 0.87 | HPGD (0.50) | LMNAHPGDCYP1A2PGRSLC6A2 | |
| SCHEMBL21808900 | 0.87 | HPGD (0.50) | LMNAHPGDCYP1A2PGRSLC6A2 | |
| SCHEMBL28742000 | 0.84 | HPGD (0.58) | LMNAHPGDCYP1A2PGRSLC6A2 | |
| SCHEMBL28135770 | 0.84 | HPGD (0.57) | LMNAHPGDCYP1A2PGRSLC6A2 | |
| SCHEMBL27600168 | 0.84 | HPGD (0.57) | LMNAHPGDCYP1A2PGRSLC6A2 | |
| SCHEMBL27618708 | 0.83 | LMNA (0.53) | LMNAHPGDCYP1A2PGRSLC6A2 | |
| SCHEMBL93360 | 0.82 | HPGD (0.52) | LMNAHPGDCYP1A2PGRSLC6A2 | |
| SCHEMBL29381744 | 0.82 | HPGD (0.52) | LMNAHPGDCYP1A2PGRSLC6A2 | |
| SCHEMBL93302 | 0.81 | HPGD (0.54) | LMNAHPGDCYP1A2PGRSLC6A2 | |
| SCHEMBL19458769 | 0.80 | LMNA (0.65) | LMNAHPGDCYP1A2PGRSLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12528965-B2 | Active energy curable resin composition, hard coat laminated film, and film for application to glass | RIKEN TECHNOS CORPORATION (JP) | 2026-01-20 | — | — | US | disclosed |
| US-12429722-B2 | Laminated glass | AGC Inc. (JP) | 2025-09-30 | — | — | US | disclosed |
| EP-3632943-B1 | ACTIVE ENERGY CURABLE RESIN COMPOSITION, HARD COAT LAMINATED FILM, AND FILM FOR APPLICATION TO GLASS | RIKEN TECHNOS CORP (JP) | 2024-10-16 | — | — | EP | disclosed |
| US-20230168530-A1 | LAMINATED GLASS | AGC Inc. (JP) | 2023-06-01 | — | — | US | disclosed |
| EP-4019561-A1 | ACTIVE ENERGY CURABLE RESIN COMPOSITION, HARD COAT LAMINATED FILM, AND FILM FOR APPLICATION TO GLASS | Riken Technos Corporation (JP) | 2022-06-29 | — | — | EP | disclosed |
| EP-2873704-B1 | Refinish coating system and repairing method for automotive resin glazing | SHINETSU CHEMICAL CO (JP) | 2022-03-23 | — | — | EP | disclosed |
| US-11248141-B2 | Active energy curable resin composition, hard coat laminated film, and film for application to glass | RIKEN TECHNOS CORPORATION | 2022-02-15 | — | — | US | disclosed |
| EP-3831601-A1 | MULTILAYER BODY | Mitsubishi Chemical Corporation (JP) | 2021-06-09 | — | — | EP | disclosed |
| US-20210147617-A1 | MULTILAYER BODY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-05-20 | — | — | US | disclosed |
| EP-2364844-B1 | POLYCARBONATE RESIN LAMINATES | SHINETSU CHEMICAL CO (JP) | 2020-12-09 | — | — | EP | disclosed |
| US-20080096029-A1 | PRIMER COMPOSITION AND COATED ARTICLE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2008-04-24 | — | — | US | disclosed |
| EP-1914259-A1 | Primer composition and coated article | Shin-Etsu Chemical Co., Ltd. (JP) | 2008-04-23 | — | — | EP | disclosed |
| US-20070219298-A1 | Curable composition and coated article | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-09-20 | — | — | US | disclosed |
| EP-1826239-A1 | Curable composition and coated article | Shin-Etsu Chemical Co., Ltd. (JP) | 2007-08-29 | — | — | EP | disclosed |
| EP-1826233-A1 | Curable composition and coated article | Shin-Etsu Chemical Co., Ltd. (JP) | 2007-08-29 | — | — | EP | disclosed |
| US-7193026-B2 | Organosilicon compound-curing composition and silicone-base coating composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-03-20 | — | — | US | disclosed |
| US-7157146-B2 | Primer composition, coating method, and coated article | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-01-02 | — | — | US | disclosed |
| US-20040260048-A1 | Organosilicon compound - curing composition and silicone-base coating composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-12-23 | — | — | US | disclosed |
| US-20040071998-A1 | Primer composition, coating method, and coated article | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-04-15 | — | — | US | disclosed |
| EP-1408082-A2 | Primer composition, coating method, and coated article | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-04-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12528965-B2 | Active energy curable resin composition, hard coat laminated film, and film for application to glass | MAT2B, MECP2, MNAT1 | LMNA 1060/4885HPGD 4500/4885CYP1A2 2182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.